Univasc
DRUG DESCRIPTION
UNIVASC® (moexipril hydrochloride), the hydrochloride salt of moexipril, has the empirical formula C27H34N2O7-HCl and a molecular weight of 535.04. It is chemically described as [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1- oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, monohydrochloride. It is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. Its structual formula is:
Moexipril hydrochloride is a fine white to off-white powder. It is soluble (about 10% weight-to-volume) in distilled water at room temperature.
UNIVASC® is supplied as scored, coated tablets containing 7.5 mg and 15 mg of moexipril hydrochloride for oral administration. In addition to the active ingredient, moexipril hydrochloride, the tablet core contains the following inactive ingredients: lactose, magnesium oxide, crospovidone, magnesium stearate and gelatin. The film coating contains hydroxypropyl methylcellulose, hydroxypropyl cellulose, polyethylene glycol 6000, magnesium stearate, titanium dioxide, and ferric oxide.
Generic Name: Moexipril
At Risk for Heart Disease?
Thanks to new technology, in just 15 seconds you can tell if you’re at risk for heart disease. Learn about this new tool. See more WebMD Videos »
Heart Health
Get the latest treatment options.

